(Q44394416)

English

Germline mutation in BRAF codon 600 is compatible with human development: de novo p.V600G mutation identified in a patient with CFC syndrome

scientific article published in May 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

2 December 2017

Germline mutation in BRAF codon 600 is compatible with human development: de novo p.V600G mutation identified in a patient with CFC syndrome (English)

1 reference

Europe PubMed Central

2 December 2017

author name string

K J Champion

1

1 reference

Europe PubMed Central

2 December 2017

C Bunag

2

1 reference

Europe PubMed Central

2 December 2017

A L Estep

3

1 reference

Europe PubMed Central

2 December 2017

J R Jones

4

1 reference

Europe PubMed Central

2 December 2017

C H Bolt

5

1 reference

Europe PubMed Central

2 December 2017

R C Rogers

6

1 reference

Europe PubMed Central

2 December 2017

K A Rauen

7

1 reference

Europe PubMed Central

2 December 2017

D B Everman

8

1 reference

Europe PubMed Central

2 December 2017

publication date

1 May 2011

1 reference

Europe PubMed Central

2 December 2017

Clinical Genetics

1 reference

Europe PubMed Central

2 December 2017

79

1 reference

Europe PubMed Central

2 December 2017

5

1 reference

Europe PubMed Central

2 December 2017

468-474

1 reference

Europe PubMed Central

2 December 2017

The RAF proteins take centre stage

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0004.2010.01495.X

21 January 2018

Mutations of the BRAF gene in human cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0004.2010.01495.X

21 January 2018

The RASopathies: developmental syndromes of Ras/MAPK pathway dysregulation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0004.2010.01495.X

21 January 2018

Germline mutations in genes within the MAPK pathway cause cardio-facio-cutaneous syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0004.2010.01495.X

21 January 2018

Germline KRAS and BRAF mutations in cardio-facio-cutaneous syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0004.2010.01495.X

21 January 2018

The cardiofaciocutaneous syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0004.2010.01495.X

21 January 2018

Neurological complications of cardio-facio-cutaneous syndrome.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0004.2010.01495.X

21 January 2018

Predicting deleterious amino acid substitutions

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0004.2010.01495.X

21 January 2018

Accounting for human polymorphisms predicted to affect protein function

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0004.2010.01495.X

21 January 2018

SIFT: Predicting amino acid changes that affect protein function

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0004.2010.01495.X

21 January 2018

Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0004.2010.01495.X

21 January 2018

PMUT: a web-based tool for the annotation of pathological mutations on proteins.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0004.2010.01495.X

21 January 2018

Differential regulation of B-raf isoforms by phosphorylation and autoinhibitory mechanisms

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0004.2010.01495.X

21 January 2018

Incidence of BRAF oncogene mutation and clinical relevance for primary cutaneous melanomas

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0004.2010.01495.X

21 January 2018

BRAF mutation in endometrial carcinoma and hyperplasia: correlation with KRAS and p53 mutations and mismatch repair protein expression.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0004.2010.01495.X

21 January 2018

Polyclonality of BRAF mutations in acquired melanocytic nevi

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0004.2010.01495.X

21 January 2018

Expression of endogenous oncogenic V600EB-raf induces proliferation and developmental defects in mice and transformation of primary fibroblasts

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0004.2010.01495.X

21 January 2018

Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0004.2010.01495.X

21 January 2018

Acute lymphoblastic leukaemia in a patient with cardiofaciocutaneous syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0004.2010.01495.X

21 January 2018

Leukemia in Cardio-facio-cutaneous (CFC) syndrome: a patient with a germline mutation in BRAF proto-oncogene.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0004.2010.01495.X

21 January 2018

Molecular and functional analysis of a novel MEK2 mutation in cardio-facio-cutaneous syndrome: transmission through four generations.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0004.2010.01495.X

21 January 2018

Hepatoblastoma and heart transplantation in a patient with cardio-facio-cutaneous syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0004.2010.01495.X

21 January 2018

Identifiers

10.1111/J.1399-0004.2010.01495.X

1 reference

Europe PubMed Central

2 December 2017

1 reference

Europe PubMed Central

2 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44394416&oldid=2020954851"